What is the management for a patient with penile ulcers and a positive Venereal Disease Research Laboratory (VDRL) test indicating syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Penile Ulcers with Positive VDRL

Treat immediately with benzathine penicillin G 2.4 million units intramuscularly as a single dose for early syphilis (primary or secondary stage), which is the most likely diagnosis given the presence of penile ulcers with positive VDRL. 1

Initial Diagnostic Approach

Before or concurrent with treatment, perform the following evaluations:

  • Darkfield microscopy or direct fluorescent antibody testing of the ulcer exudate - this is the definitive diagnostic method for early syphilis when lesions are present and should be prioritized 1, 2
  • Quantitative nontreponemal test (VDRL or RPR) - document the baseline titer as this will be essential for monitoring treatment response 1, 2
  • Treponemal test confirmation (FTA-ABS or TP-PA) - to confirm true syphilis infection versus false-positive VDRL 2, 3
  • HIV testing - mandatory for all patients with syphilis, as HIV coinfection affects management and follow-up 1
  • Evaluation for other sexually transmitted infections - including HSV culture or antigen testing and consideration of chancroid (Haemophilus ducreyi) if in endemic areas 1

Treatment Algorithm Based on Stage

Primary Syphilis (Most Likely with Penile Ulcer)

  • Benzathine penicillin G 2.4 million units IM as a single dose 1, 3, 4
  • This covers the typical presentation of a painless penile chancre with positive serology 4

If Neurologic or Ocular Symptoms Present

  • Perform lumbar puncture for CSF examination - any patient with neurologic symptoms (headache, vision changes, hearing loss, confusion) or ocular manifestations (uveitis, neuroretinitis) requires CSF evaluation 1
  • If neurosyphilis confirmed: Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours) for 10-14 days 1

Penicillin Allergy Considerations

  • For non-pregnant patients with early syphilis: Doxycycline 100 mg orally twice daily for 14 days is an acceptable alternative 1, 3
  • For pregnant patients or neurosyphilis: Penicillin desensitization is mandatory, as penicillin is the only proven effective treatment 1

Critical Follow-Up Protocol

  • Clinical and serologic evaluation at 6 and 12 months post-treatment using quantitative nontreponemal tests (same method, same laboratory) 1, 3
  • Treatment success is defined by a fourfold decline in nontreponemal titer (e.g., from 1:32 to 1:8) within 6-12 months 1, 2, 3
  • If HIV-positive: More frequent monitoring at 3-month intervals instead of 6-month intervals 1, 3

Common Pitfalls to Avoid

  • Do not delay treatment waiting for darkfield results - if clinical suspicion is high and diagnostic capabilities are limited, treat empirically for syphilis 1
  • Do not use treponemal test titers to monitor treatment response - these remain positive for life in most patients regardless of cure 1, 2, 3
  • Do not compare VDRL and RPR titers directly - use the same test method throughout follow-up 1, 2
  • Do not assume treatment failure with persistent low titers - some patients remain "serofast" with stable low titers (typically <1:8) despite adequate treatment 3

Partner Management

  • All sexual contacts within the past 90 days (for primary syphilis) should be evaluated clinically and serologically and treated presumptively 1
  • Sexual transmission occurs only when mucocutaneous lesions are present, which is uncommon after the first year of infection 1

Special Consideration: Jarisch-Herxheimer Reaction

  • Warn patients about possible acute febrile reaction within 24 hours of treatment, characterized by fever, headache, and myalgia 1
  • This reaction is common in early syphilis and does not indicate treatment failure 1
  • Antipyretics may be recommended, though no proven prevention methods exist 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Syphilis Diagnosis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.